Synchron
The brain-computer interface device powering autonomy
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- synchron.com
- Total Funding
- $325.0M
- Last Round
- $200.0M Series DNov 2025
About
Synchron is developing a minimally invasive brain-computer interface (BCI) called Stentrode, implanted via endovascular procedure without open brain surgery. It enables people with paralysis to control digital devices using thoughts, restoring autonomy and addressing unmet medical needs in neurology.
Tech Stack
StentrodeEndovascular Implantation
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free Account